GB507376A - Process of preparing an antipoliomyelitis serum and the product thereof - Google Patents

Process of preparing an antipoliomyelitis serum and the product thereof

Info

Publication number
GB507376A
GB507376A GB15795/38A GB1579538A GB507376A GB 507376 A GB507376 A GB 507376A GB 15795/38 A GB15795/38 A GB 15795/38A GB 1579538 A GB1579538 A GB 1579538A GB 507376 A GB507376 A GB 507376A
Authority
GB
United Kingdom
Prior art keywords
virus
serum
antipoliomyelitis
strains
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB15795/38A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WESTERN RESERVE UNIVERSITY
Original Assignee
WESTERN RESERVE UNIVERSITY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WESTERN RESERVE UNIVERSITY filed Critical WESTERN RESERVE UNIVERSITY
Publication of GB507376A publication Critical patent/GB507376A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

507,376. Antipoliomyelitis serum. WESTERN RESERVE UNIVERSITY. May 26, 1938,' No. 15795. Convention date, May 29, 1937. [Class 81 (i)] A serum effective against the virus of poliomyelitis is obtained by immunizing an animal by successive injections of poliomyelitis virus fortified with products of metabolism of intestinal bacteria and obtaining a serum from the blood of the animal. Material for fortifying the virus may for example comprise the endotoxins from strains of typhoid, paratyphoid and coli bacteria, together with the exotoxins from the growth of these strains in glucose broth. A solution of the virus in normal saline with which the fortifying material is to be admixed may be obtained by adsorbing the virus on aluminium hydroxide gel and eluting the adsorbed virus.
GB15795/38A 1937-05-29 1938-05-26 Process of preparing an antipoliomyelitis serum and the product thereof Expired GB507376A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US507376XA 1937-05-29 1937-05-29

Publications (1)

Publication Number Publication Date
GB507376A true GB507376A (en) 1939-06-14

Family

ID=21967099

Family Applications (1)

Application Number Title Priority Date Filing Date
GB15795/38A Expired GB507376A (en) 1937-05-29 1938-05-26 Process of preparing an antipoliomyelitis serum and the product thereof

Country Status (1)

Country Link
GB (1) GB507376A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3183161A (en) * 1955-05-02 1965-05-11 Parke Davis & Co Aqueous resuspension vaccine product of aluminum phosphate-adsorbed poliomyelitis virus antigen, and production process
WO1983003972A1 (en) * 1982-05-06 1983-11-24 Massachusetts Institute Of Technology Production of enterovirus neutralizing antibodies from vp1

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3183161A (en) * 1955-05-02 1965-05-11 Parke Davis & Co Aqueous resuspension vaccine product of aluminum phosphate-adsorbed poliomyelitis virus antigen, and production process
WO1983003972A1 (en) * 1982-05-06 1983-11-24 Massachusetts Institute Of Technology Production of enterovirus neutralizing antibodies from vp1

Similar Documents

Publication Publication Date Title
US2563794A (en) Vitamin b12
BE777689A (en) NEW DERIVATIVES OF IMIDAZOLINE, THERAPEUTIC COMPOSITIONS CONTAINING THEM AND THE PROCESS FOR THE PREPARATION OF THESE DERIVATIVES AND OF THESE COMPOSITIONS
GB507376A (en) Process of preparing an antipoliomyelitis serum and the product thereof
GB2020665A (en) Acyl-N-acetylmuramylpeptide- antigen conjugate
Anchel et al. Antibiotic Substances from Basidiomycetes: X. Fomes Juniperinus Schrenk
Phillips et al. Passive Transfer of Immunity to Sarcoma I with Serum.
Kirby Carcinogenic effect of aminoazobenzene
Nagington The sensitivity of Salmonella typhi to the bactericidal action of antibody
ES334055A1 (en) Procedure for the preparation of useful products for radiodiagnosis. (Machine-translation by Google Translate, not legally binding)
CA1020565A (en) N,n-dimethyl-o-pyrazolylcarbamic acid esters, process for their preparation and their use as insecticides
GB1032333A (en) Process for the production of compounds of the b-vitamin group
Sabin Rôle of Certain Anaerobic Toxins in Pneumococcus Infection.
GB1445802A (en) Pharmaceutical compositions
GB1336535A (en) Process for the production of 2,6-di-tert-butyl-4-alkoxyphenols
AU4386772A (en) Improvements in or relating to novel compounds for the treatment of excess lipidic and cellulitic stresses, and process for preparing said compounds
GB1254948A (en) Antivirial substance
CA979916A (en) Imino formic acid alkyl esters, process for their preparation, and their use as insecticides and acaricides
GB412377A (en) Manufacture of a remedy for tuberculosis or the like
BE780167A (en) PROCESS FOR PREPARING SODIUM CITRATE AND SODIUM ISOCITRATE BY FERMENTATION
CA861483A (en) Process for producing l-threonine by fermentation
CA885980A (en) Process for producing l-threonine by fermentation
CA976565A (en) Process for the preparation of 1-isopropylamino-3-(4'-acetamidophenoxy)-2-propanol
荒川雅男 Pyruvic Acid Content in Human Milk with Different Arakawa's Reaction
ES393227A1 (en) A procedure for the preparation of the compound 1,2-alfametilen-6,7-alpha-difluormethylen-20-espirox-4-en-3-ona. (Machine-translation by Google Translate, not legally binding)
BE769137A (en) PROCESS FOR THE PREPARATION OF 1-HYDROXY, ORGANO-1,1- DIPHOSPHONIC ACIDS AND NEW PRODUCTS THEREFORE